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The mechanism of immunological tolerance (for review see ref.  1)  is still largely 
unknown.  Thus,  it is not known whether  tolerance is caused by inactivation or by 
killing of the immunocompetent cells. In the course of the normal immune response 
antibody-secreting cells, as well as antigen-binding cells, can be detected. Antibody- 
secreting cells can be enumerated in vitro by the technique of local hemolysis in gel 
(2)  and are generally called plaque-forming cells (PFC).I Antigen-binding cells may 
be visualized by their ability to bind particulate antigens,  such  as sheep red  cells 
(SRC), to their surfaces and these cells have been termed rosette-forming cells (RFC) 
(3, 4). It is likely that RFC represent a mixture of antibody-secreting and nonsecret- 
ing cells (5). 
Howard et al. (6) studied the RFC response in the spleens of mice tolerant to pneu- 
mococcal polysaccharide. Although serum antibodies could not be detected in these 
animals, a considerable number of RFC was found, which  in  fact was  larger in  the 
"tolerant" than in the optimally immunized animals. They suggested that antibody- 
secreting cells were present in  these  animals but  the humoral  antibodies produced 
were  neutralized extracellularly by persisting undegraded  antigen.  To  test  if  this 
hypothesis was true for another polysaccharide, the presence of antigen-binding ceils 
was examined in mice tolerant towards polysaccharide of Escherichia  coli  origin  as 
judged by the absence of antibody production at the cellular level. 
It  has  recently  been  shown  that  a  significant proportion  of  RFC  against 
sheep red blood cells are  thymus-derived  lymphocytes  (T-cells)  (5).  SRC  are 
known to be dependent on the presence of T-cells for induction of an optimal 
antibody response (for reviews see ref. 7). Recently it has been shown that coli 
polysaccharide  is  a  nonthymus-dependent  antigen3  Therefore,  experiments 
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were performed to study the existence of RFC  of T-cell origin also against such 
a  nonthymus-dependent  antigen. 
Materials  and Methods 
Mice.--Inbred  CBA mice 2-5 months old were used. 
Extraction and Detoxification of Coli Polysaccharide (CPS).--Lipopolysaccharide  (CPS)  of 
E. coll 055:B5 was obtained by phenol extraction according to the method of Westphai, et al. 
(8) with some modifications (9). 
Detoxiflcation was performed with weak alkali as described by Neter et al.  (10). The de- 
toxified material was kept as a dry substance at 4°C and was dissolved in saline immediately 
before use. 
Immunizatlons.--For  an optimal antibody response 0.01 mg of CPS  was injected intra- 
peritoneally in 0.2 ml of balanced salt solution (BSS) (11). SRC kept in Alsever's solution were 
washed once in BSS before immunization and 4  )<  l0  s SRC suspended in BSS were injected 
intraperitoneally. 
Tests for PFC and RFC were made 5 days after the injection of the relevant antigen if not 
otherwise stated. 
Tolerance Induction.--Tolerance  was induced by five injections of 3 mg of alkali detoxified 
CPS  during  14  days and maintained by weekly injections of 3 mg of CPS.  Routinely the 
tolerant mice were given a test dose of 0.01 mg of CPS 7 days triter the last tolerance-main- 
taining dose and assayed 5 days later for PFC and RFC. 
Local Hemolysis in Gel Assay.--The number of PFC was assayed according to Jerne and 
Nordin (2) as modified by Mishell and Dutton (12). The spleens were pressed through a 60- 
mesh stainless steel screen into BSS.  Cell clumps were removed by filtration through gauze, 
the cells were washed three times in BSS, and suspended to the appropriate cell concentration 
in BSS. The number of viable cells was estimated with the trypan blue-exclusion technique. 
0.1 ml of the cell suspension and 0.025 ml of the relevant red blood cells diluted 1:7.5  in BSS 
were added to 0.5 ml of a 0.5% agarose solution in glass tubes kept at 45°C. The mixture was 
poured onto microscope glass slides. Duplicate slides were made for each cell suspension. The 
slides were put on racks and incubated at 37°C with guinea pig complement diluted 1:20 in 
BSS. Plaques were read without staining in indirect light using a magnifying glass. 
Cellular antibody synthesis to CPS was studied by coating SRC with CPS according to 
M611er (13). To calculate the number of PFC directed against CPS, the number of PFC against 
untreated SRC was subtracted from the number of PFC against CPS-sensitlzed SRC obtained 
with the same cell suspension. Since CPS stimulates 19S antibody synthesis exclusively for a 
prolonged period, only direct PFC were studied (14). 
RFC Assay.--The number of RFC was assayed by a slight modification of the centrifuga- 
tion-suspension technique of McConnell et al.  (15). The spleen cells, which had been washed 
three times, were adjusted to a cell density of 10 )<  106 cells/ml in calcium-free BSS. 0.5 ml of 
this cell suspension was mixed with 0.5 ml of a suspension of CPS-sensitized CBA mouse red 
cells (CPS-MRC) containing 50 )<  106 red cells/ml in a small tube. Accordingly, the propor- 
tion of spleen cells to red cells was 1 : 5. The CPS was absorbed onto CBA mouse erythrocytes 
with the technique used for sensitization of SRC described above. The mixture of spleen cells 
and CPS-MRC was spun at 100 g for 10 min. The cells were suspended by gently turning the 
tube repeatedly, and the number of RFC was determined by counting in a hemocytometer. 
Cells with five or more red cells  adhering were regarded as RFC. 45,000  cells  of each cell 
suspension were scored. The cells were kept at +4°C during the assay. 
Anti-Theta  Serum  Treatment.--Anti-theta  serum was raised in  adult  AKR mice by im- 
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given once a week during 4 wk and thereafter once every 14 days. Serum was collected 6 days 
after the last immunization. 100%  of thymocytes, 20-40%  of spleen cells, and 0% of bone 
marrow cells were killed by the serum. The cytotoxic titer of the serum against CBA thymus 
cells was 1 : 64-1 : 128. Absorption with bone marrow cells had no effect whereas absorption with 
thymocytes or brain cells completely abolished the cytotoxicity against thymocytes. Further 
specificity tests have been performed by Greaves and M611er  (5).  Normal AKR serum was 
used as control serum. Treatment of spleen cells with anti-theta serum was performed in vitro. 
Approximately 100 )<  106 washed spleen cells were treated with 0.3 ml of undiluted anti-theta 
serum for 30 mill at 37°C. Thereafter the spleen cells were washed once and 0.3 ml of a  1:6 
dilution of lyophilized guinea pig complement was added to the cells and the incubation con- 
tinued for 30 min at 37°C. Finally, the cells were washed and resuspended in BSS to the ap- 
propriate concentration. 
Anti-Immunoglobulin Serum.--The rabbit anti-mouse immunoglobulin serum was prepared 
as described by MSller (22). The serum was absorbed with CPS-coated MRC to remove anti- 
bodies against CPS and MRC. 
RESULTS 
The PFC and RFC Responses  against CPS.--Spleen  cells from normal ani- 
mals or animals immune or tolerant against CPS were tested for their numbers 
of PFC and RFC (Table I). In immune mice the assay was done 5 days after 
an injection of 0.01 nag of CPS at the peak of the PFC response (ll). In one of 
the tolerant groups (tolerant mice A), the assay was done 5 days after the last 
injection  of  the  tolerance-maintaining  dose  of  3  mg  of  CPS.  In  the  other 
tolerant group (tolerant mice B), the animals received an injection of 0.01  mg 
and  were tested  5  days later.  Although  the number  of PFC  increased  from 
0.5 PFC/106 spleen cells in normal animals to 209 PFC in optimally immunized 
animals,  there was only a  fivefold increase  of  the number  of RFC  after an 
optimal immunization. In animals tolerant to CPS, as judged by no or only a 
minimal  PFC  response,  no  decrease  of  the  number  of  RFC  was  found  as 
compared to  the  number  in  normal mice.  In  fact the  number  of RFC  was 
slightly increased in the group tolerant mice A  (P  <  0.05)  and highly signifi- 
cantly increased in the group tolerant mice B  (P <  0.001). However, the num- 
ber of RFC was not as high in tolerant mice as in immune mice. 
Specificity  of RFC against CPS.--The presence of RFC  against autologous 
erythrocytes  both  in  thymus  and  in  spleen  has  been  observed  (Micklem, 
personal communication). To test whether such a  phenomenon could explain 
the  RFC  found  in  tolerant  animals,  the  number  of RFC  against  untreated 
CBA  erythrocytes was tested  in mice unprimed,  primed,  or tolerant  against 
CPS  (Table II). Only approximately 30 RFC/106  spleen cells were found  in 
normal and tolerant animals.  In mice given 0.01  mg of CPS and assayed for 
auto-RFC  5  days  later,  the  number  of  RFC  was  58/106  spleen  cells.  This 
number is not significantly different from that in normal and tolerant animals. 
This is in contrast to the results of Micklem, which  indicated  an increase of 
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the low RFC  counts obtained in the present  experiments,  the variation  is quite 
pronounced. 
If  the  RFC  against  CPS-MRC  are  specific for  CPS,  it  should  be  possible 
to inhibit them by pretreating  the spleen cells with free CPS before adding the 
sensitized  MRC.  Table  III  shows  that  such  treatment  inhibited  the  forma- 
tion of RFC  completely or almost completely. 
TABLE  I 
Cellular Immune Response against CPS in Spleens from Normal, Immune,  and Tolerant Mice 
Mice  PFC/106 spleen cells  RFC/106 spleen cells  No. of mice 
Normal  --0.30  4-  0.15  (0.5)*  1.97  4-  0.03  (93)  9 
Immune*  2.32  4-  0.09  (209)  2.71  4-  0.07  (513)  10 
Tolerant A§  --0.23  4-  0.22  (0.6)  2.21  4-  0.14  (164)  5 
Tolerant B][  0.34  4-  0.22  (2.2)  2.38  4-  0.03  (240)  10 
* The figures are given in 10logs for the mean 4- standard error. The corresponding antilogs 
for the mean are given in parenthesis. 
Tested 5 days after an injection of 0.01 mg of CPS. 
§ Tested 5 days after the last tolerance-maintaining dose of 3 mg of CPS. 
I[ Tolerant mice B  were given 0.01 mg of CPS 7 days after the last injection of 3 mg of 
CPS and their spleens were assayed 5 days later. 
TABLE  II 
Number of RFC against Autologous Red Blood Cells 
Mice  RFC/106 spleen cells  No. of mice 
Normal  1.46  4-  0.09  (28.8)*  7 
Immune~:  1.54  4-  0.09  (35.0)  5 
Tolerant§  1.76  4-  0.12  (57.7)  5 
* 10logs for the mean -4- standard error. Antilogs for mean in parenthesis. 
:~ Tested 5 days after an injection of 0.01 mg of CPS. 
§ Mice tolerant to CPS were given 0.01 mg of CPS 7 days after the last tolerance-main- 
taining dose and assayed 5 days later. 
Lipopolysaccharides  are  known  to  be  "sticky"  and  tend  to  adhere  to  cells 
passively.  The conjugation method used in this study depends  on such a  reac- 
tion.  It  seems  possible  that  also  the  CPS-sensitized  MRC  become sticky  and 
therefore form nonspecific rosettes. To test this possibility the spleen cells were 
pretreated  with  rabbit  anti-mouse  immunoglobulin  for  30  rain  since  the  spe- 
cific  receptors  for  antigens  are  considered  to  be  immunoglobulin-like  mole- 
cules  (for  reviews see  ref. 16).  As  shown  in  Table  III  no  or  only  a  few RFC 
against CPS-RFC  were found after such a  treatment.  Thus it seems likely that 
the RFC  against  CPS-MRC  represents  a  specific binding  of the CPS-determi- 
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Characteristics  of Antigen-Binding  Cells  in  Tolerant  and  Immune  Mice.- 
It could be argued that the large doses of CPS used to induce tolerance cause 
a  nonspecific toxic depression of the PFC  response without affecting the de- 
velopment of  RFC  to  a  similar extent,  which could explain the  RFC  found 
in tolerant animals. The results given in Table IV show that this was not the 
case.  Mice tolerant to CPS gave a  normal PFC response to SRC 5 days after 
an injection of 4 >(  l0  s SRC. 
TABLE  III 
Number of RFC against CPS after Preincubation of Spleen Cells with Free CPS or 
Anti-Immunoglobulin  Serum* 
MiceJ; 
Preincubation with 
CPS  Anti-Ig 
Normal  22, 0, 22§  0, 22, 44 
Immune  44, 0, 22  89, 67, 44, 44 
Tolerant  44, 0, 22  22, 14, 44, 22, 22, 0 
* The spleen cells were incubated either with free CPS at a concentration of 1 mg/ml or 
anti-immunoglobulin serum at a dilution of 1/20 for 30 min at +4°C before mixing with 
CPS-sensitized SRC. 
2~ Designations of mice as in Table II. 
§ Each figure represents one experiment, in which one to three spleens were pooled. 
TABLE IV 
Specificity of Tolerance to CPS 
Mice  PFC/106 spleen cells*  No. of mice 
Normal  2.76  4-  0.07  (582):~  5 
Tolerant  2.88  -4- 0.03  (757)  5 
* The number of PFC against  SRC was assayed in spleens from normal mice or mice 
tolerant to CPS 5 days after an intraperitoneal injection of 4 X  l0  s SRC. 
J; PFC numbers are given in 10logs for the mean 4- standard error; the corresponding anti- 
logs are given in parenthesis. 
Another possibility is that  the  RFC  in tolerant mice are  cells which  pro- 
duce  antibodies directed  against  other  determinants than  those  antibodies 
causing plaques in optimally immunized animals. It might be speculated that 
these  determinants occur  in  a  very  low  frequency and  therefore  can  cause 
formation of rosettes but not of plaques. This implies that rosette formation 
is less dependent on a high density of the antigenic determinants on the erythro- 
cytes than is the plaque formation. This was tested in an indirect way (Table 
V). Mice were immunized against SRC and their spleen cells assayed for PFC 
and  RFC  against both  untreated  SRC  and  CPS-sensitized SRC.  It  can be 1020  ANTIGEN-BINDING CELLS IN MICE 
assumed that  some  of  the  antigenic determinants specific for  the  SRC  were 
covered by the CPS at the coating. No inhibition of the PFC was found when 
CPS-SRC were used instead of ordinary SRC. On the other hand, there was a 
depression of 40% of the RFC when tested against CPS-RFC. Thus, it seems 
likely that  the  above assumption was  not true.  On the  contrary the forma- 
tion of  rosettes seemed to be more dependent on a  high density of the anti- 
genic determinants than the formation of plaques. 
TABLE  V 
Per Cent Inhibition of PFC and RFC against SRC after Conjugation of SRC with CPS 
Experiment No.  PFC  RFC 
1  15.1  53.5 
2  -9.5  27.4 
3  0.9  31.4 
4  -7.6  47.1 
Mean  -0.3  4-  5.6  39.9  ±  6.2 
Mice were immunized with SRC 5 days before the test. The numbers of PFC and RFC 
against untreated and CPS-sensitized SRC were compared and the per cent inhibition, when 
CPS-sensitized SRC were used, was calculated. 
TABLE  VI 
Per Cent Inhibition of PFC and RFC after Treatment with Anti-Theta Serum 
Mice  PFC  RFC  No. of mice 
Immune against CPS*  2.8  4-  2.9  --0.5  4-  4.1  4 
Tolerant against CPS*  N.C.$  -- 1.0  4-  7.1  4 
Immune against SRC§  --3.0 -4- 2.7  31.0  4-  1.0  5 
* Mice immune or tolerant against CPS were treated  as in Table II and assayed against 
CPS. 
~: N.C., not calculated. 
§ Tested against SRC 5 days after an optimal immunization  with SRC. 
Both bone marrow-derived (B-cells) and thbanus-derived (T-cells) lympho- 
cytes can give rise to RFC against certain antigens (5). If tolerance induction 
inactivates  B-cells  preferentially,  leaving  T-cells  relatively  unaffected,  the 
increased number of RFC in tolerant animals could be of T-cell origin. To test 
if this alternative is true, spleen cells from tolerant animals were assayed for 
RFC and PFC after treatment with anti-theta serum (Table VI). No inhibi- 
tion of the RFC was obtained. Furthermore, when mice optimally immunized 
against CPS were tested for the presence of thymus-derived RFC in the same 
way, no such RFC were detected. In contrast to this, 31% of the RFC against 
SRC in spleens from mice immunized against SRC could be inhibited by anti- OLOF  SJOBERG  1021 
theta serum treatment.  Thus,  CPS,  in contrast to SRC,  will not stimulate T- 
cells to a RFC response. 
The effect of anti-theta  serum on  PFC  was also tested.  There was no de- 
crease of the number of PFC, neither against CPS nor against SRC. 
DISCUSSION 
Thus it was found that mice tolerant to CPS, as judged by the absence of an 
antibody  response,  still  can  respond  with  an  increased  number  of  antigen- 
binding cells against this antigen. The antigen-binding cells (--  RFC) in these 
animals were found to be specific against  CPS.  Only very few rosettes were 
obtained when mixing spleen cells with autologous red cells.  The formation of 
rosettes could be inhibited  completely or almost completely by pretreatment 
with  free  CPS  or  rabbit  anti-mouse  immunoglobulin  serum.  The  inhibition 
by rabbit  anti-mouse immunoglobulin  serum  shows  that  the  binding  of the 
CPS-sensitized MRC to the spleen cells is not due to a nonspecific adherence 
caused by the stickiness of the CPS,  but to a  binding to receptors which  are 
immunoglobulins or shear antigenic determinants with immunoglobulins. 
The  present  findings  cannot  be  explained  by  postulating  that  antibodies 
secreted  by  antibody-producing  cells  in  tolerant mice  are neutralized  extra- 
cellularly by excess antigen, as was suggested by Howard et al. (6), since anti- 
body production  was measured at the  cellular level.  Thus,  tolerance to  CPS 
appears to inhibit selectively the steps leading to the appearance of antibody- 
secreting  cells  without  affecting those  resulting  in  the  development of  RFC 
to a  similar extent.  In fact, Howard has recently reinvestigated the immune 
status  in  mice tolerant  to pneumococcal polysaccharide  at  the  cellular  level 
and  has  also  found  antigen-binding  cells  in  situations  where  the  antibody- 
secreting cells are paralyzed by very high antigen doses (personal communica- 
tion). 
The finding  of antigen-binding  cells  in  tolerant  animals  is  not  unique.  It 
has been reported  earlier by Howard et al.  (6)  as mentioned  above,  by Ada 
(17),  and  by Naor  and  Sulitzeanu  (18).  In  contrast  to  the  present  results, 
neither Ada nor Naor and  Sulitzeanu  found  any increase of  antigen-binding 
cells over the number found in normal animals. This discrepancy might depend 
on differences in the properties of the antigen used, in the scheme for tolerance 
induction, and in the methods for detection of antigen-binding cells. 
A number of different alternatives seem possible to explain the finding of an 
increased number of RFC in tolerant animals.  (a) The receptors on the RFC 
in tolerant animals may be directed against other antigenic determinants than 
are the antibodies secreted by the PFC  in  optimally immunized animals.  In 
terms  of this  possibility it  can be  assumed  that  the  antigenic  determinants 
occur in such a low density on the CPS-sensitized SRC that antibodies against 
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present  findings that  the formation of rosettes  is more dependent  on  a  high 
density of the antigenic determinants than the formation of plaques.  Further- 
more, Humphrey and Dourmashkin (19)  found that one or two 19S antibody 
molecules attached to a red cell will cause lysis of the cell. Finally, it is unlikely 
that the RFC present in tolerant animals are directed against other determi- 
nants  than  are the  antibodies causing plaques,  also because of recent  results 
of M611er et al.  (to be published).  They studied  the cellular response in mice 
tolerant against a hapten (NNP) and found a marked decrease of the number 
of PFC together with a moderate depression of the RFC response as compared 
with  the responses  in  immune mice,  which  is in  agreement with  the present 
results. 
(b) Tolerant animals may contain cells actually secreting antibodies directed 
against the same determinants as the antibodies producing plaques in inmmne 
animals. These antibodies may be of very low affinity, however, in concordance 
with  earlier  findings,  that  tolerance  induction  affects preferentially the  pro- 
duction  of high  affinity antibodies  (20).  It would  be possible that  cells pro- 
ducing antibodies of a very low affinity are detected as RFC but not as PFC. 
This explanation seems unlikely, however, if one considers that the receptors on 
the RFC must have an affinity sufficiently high to bind the antigen during the 
suspension  of the  cell pellet.  It is  assumed  in  this  discussion  that  the  anti- 
bodies produced  have the  same properties  as the  receptors on the  precursor 
cells  for antibody  production  (21).  Furthemlore,  the  finding  of  M611er (22) 
that  50-100%  of  a  spleen  cell  population  may  occasionally  be  detected  as 
PFC  suggests that most of the antibody-secreting cells are,  in fact, detected 
as PFC. 
(c)  Tolerance  induction  leads  to  blockage  of  antibody  secretion  without 
affecting division  and  differentiation  of precursor  cells  for antibody produc- 
tion.  It can be argued against this possibility that RFC are fewer in tolerant 
than in optimally immunized animals. This would not be the case if tolerance 
means simply inhibition of secretion of antibodies. 
(d)  Tolerance may be caused by the inhibition of division and differentiation 
of antigen-sensitive  cells.  The RFC  in tolerant animals may in  that  case be 
formed by bone marrow-derived 1ymphocytes (B-cells), which do not give rise 
to  PFC  or  by  thymus-derived  lymphocytes  (T-cells).  Recent  findings  have 
shown that T-cells and  B-cells cooperate in the antibody response to certain 
antigens (for reviews see ref. 7). It has also been found that a high proportion 
of the RFC appearing in mice immune to SRC are T-cells, using experimental 
systems involving isoantigenic markers  (H-2,  theta)  on T-cells  (5).  The  coli 
polysaccharide is not dependent on T-cells in order to induce a humoral anti- 
body response3 This does not necessarily imply that there are no receptors for 
the  antigen  among the T-cells. The independence  of T-cells for an  adequate 
immune response to CPS may be related to the fact that the structure of this OLOF SJOBERG  1023 
antigen  is  characterized  by  repeating  units  of  identical  determinants.  Such 
an  antigen  may bind  well to  bone marrow precursor  cells  with  multivalent 
receptors and stimulate them to antibody production without the presence of 
T-cells.  Thus,  it would  be possible that  T-cells are  stimulated  to respond  in 
tolerant animals.  Such  cells would  be revealed as  RFC  but not as PFC  and 
may therefore be the explanation for the finding of RFC in tolerant animals. 
However, as shown above there  was no inhibition of RFC in tolerant  animals 
against  CPS  after treatment  with  anti-theta  serum.  The  RFC  against  CPS 
are therefore not likely to be T-cells but rather B-cells. 
It is possible that  a  high dose of antigen  will  only stop division  of B-cells 
with receptors for the antigen above a certain level of affinity. Such cells would 
give rise to PFC after an optimal immunization dose. B-cells with receptors of 
lower affinity would be stimulated to divide but are not driven through all the 
stages of division and differentiation to antibody production after an optimal 
immunization dose because the energy of binding of the antigen to the receptors 
would be too low. These cells are not prevented to divide in tolerant animals 
since they escape tolerance due to the low affinity of their receptors. Such cells 
with rather low affinity receptors could therefore be the explanation for the RFC 
in tolerant animals. If this alternative is correct it would imply that a level of 
affinity sufficiently high to bind the antigen to the cell surface is not high enough 
to induce antibody production. However, from these experiments it cannot be 
excluded that  at least some of the RFC  in tolerant mice represents true tol- 
erant cells, i.e., cells that after an optimal stimulation would have given rise to 
antibody production but have become inactivated by the large antigen doses. 
This would mean that tolerance is caused by inactivation instead of killing of 
immunocompetent precursor ceils for antibody production. 
Even  after an  optimal immunization  no  theta-positive  RFC  against  CPS 
could be detected.  Because of the low number of RFC against CPS in normal 
mice, and the uncertainty connected with an assay of the percentage of theta- 
positive RFC at such low values, no attempt was made to determine the pres- 
ence of RFC of thymic origin in normal mice. Therefore it cannot be decided 
at  this moment whether  the lack of theta-positive RFC  is due  to a  lack  of 
receptors for the antigen  among the T-cell population  or tolerance induction 
or lack of stimulation of immunocompetent T-cells. 
However, the absence of theta-positive RFC against CPS can explain some 
of the features of the immune response against this antigen.  The inability of 
T-cells to increase the response  follows  logically since  there  are no RFC  of 
thymic origin  to cooperate with  for the B-cells. Low zone tolerance has not 
been possible to obtain to CPS  (11)  or to pneumococcal polysaccharide  (23) 
which both are thymus-independent antigens (5,  24). This is to be expected if 
low zone tolerance means  inactivation  of T-cells,  as suggested  by Mitchison 
and  Rajewski  (personal  communication).  It follows from this  reasoning  that 1024  ANTIGEN-BINDING CELLS IN MICE 
low zone tolerance should not be possible to obtain to any thymus-independent 
antigen. 
SUMMARY 
The number of PFC and of RFC was studied in mice which were unimmun- 
ized,  immunized,  or  tolerant  against  lipopolysaccharide  of  E.  coli  055:B5 
origin.  The number  of PFC/10 G spleen  cells  increased  from 0.5  in normal  to 
209 in  immunized mice.  The corresponding figures for RFC  were 93  and  513 
RFC/106  spleen  cells.  In tolerant  animals,  which  contained  few  or no  PFC, 
the number of RFC was increased as compared to that found in unimmunized 
mice. The formation of rosettes was specific, since their formation was inhibited 
by soluble coli polysaccharide and by rabbit antisera  against mouse immuno- 
globulins.  The antigen-binding cells were not derived from thymus, neither  in 
immune  or tolerant mice,  because they did not carry the theta  antigen.  It is 
suggested that the majority of antigen-binding cells present in tolerant animals 
are cells having receptors for the antigen of rather low affinity. The relevance of 
these findings for the induction of high and low zone tolerance is discussed. 
The technical assistance of Miss Gun Stenman  and  Miss Lena S6derstrSm is gratefully 
acknowledged. 
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